FDA Moves to Ban Trans Fats from Food Supply

The FDA recently proposed actions to remove trans fats, the artery clogging substance and major cause of heart disease in the U.S., according to recent New York Times article. Under the proposal, the agency would declare partially hydrogenated oils, the source of trans fats, as unsafe. For companies, this means that they would have to prove scientifically that partially hydrogenated oils are in fact safe to the public’s health. Scientific evidence over the past years has shown the contrary. Although some foods that you pick up off the shelves might state that they have 0% trans fat, they may actually contain some levels of trans fat. The FDA legally allows a company to market their product as having 0% trans fat if the product has less than .05% trans fat per serving. Therefore, if a product has .045% trans fat per serving, the company is allowed to put 0% on their nutrition label. However, if you eat more than 1 serving of this product, you are consuming way more artificial trans fats than you think you are! In order to find out if your packaged foods actually contain trans fat, check the ingredients list for “partially hydrogenated oils”. Artificial trans fats are created when liquid oil is treated with hydrogen gas and made solid. These fats are long-lasting and are popular in frying and baking. They can be found in margarine, which is cheaper than butter. Research has shown that trans fats are the worst kinds of fat because they raise the levels of LDL (bad cholesterol and can lower the levels of HDL (good cholesterol). The agency’s commissioner said that the new rule could prevent 20,000 heart attacks and 7,000 deaths from heart disease each year. Call us today for a free consultation or chat with one of our live agents 24/7.

Dear Friends and Clients,

In furtherance of our firm’s culture of commitment to always act with compassion, concern and commitment to our clients, community and colleagues, we have been taking precautions to ensure that we are still fulfilling our ethical and moral obligations while prioritizing health, wellness and safety of all we can.

As you know, the COVID-19 pandemic has introduced changes to many lives and businesses in our communities, and around the world. We, much like our neighbors and friends, have been taking precautions to ensure that we are still fulfilling our ethical and moral obligation to our clients, while also prioritizing the health, wellness and safety of our employees.

Until further notice, our offices will be closed to the public to encourage social distancing and to help prevent the spread of COVID-19. Our team is still hard at work, many from home, and you may still call, email, live chat or video conference us if you or a loved one is seeking legal assistance. As the first law firm to offer our clients secure online access to their case file more than a decade ago, we have always been believers in using technology to make life easier and information more accessible. In these present times it has been a smooth transition for us to continue to offer our clients the same seamless and thorough service that you deserve and are accustomed to.

This pandemic is unlike anything any of us have faced in our lifetimes, and while we can continue to emotionally support one another through it all, staying home and keeping your distance is vital to the health and wellness of our communities. It does not feel good to break routines, cancel events and retreat from our normal, day-to-day socializing, but let us remember that, in times of strife, prior generations were asked to go to war and we are simply being asked to stay home. Your isolation equals more lives saved, and more time for medical providers to prepare for the treatment of patients battling COVID-19.

When the dust settles, we will join together with a greater appreciation for our lives, local businesses, loved ones and health. Until then, we will continue to offer guidance from a safe distance.

Very truly yours,

Andrew G. Finkelstein and the staff of Finkelstein & Partners, LLP